Acadia Pharmaceuticals | ACAD - Ativos





Ativos Alterar Data
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
ALKERMES USD 4.26B 1.77B 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Biogen USD 29.48B 43.6M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Cara Therapeutics USD 32.07M 6.95M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Cytokinetics USD 1.27B 151.06M 2026-03
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Incyte USD 7.34B 381.14M 2026-03
J&J USD 200.89B 1.68B 2026-03
Moderna USD 11.49B 850M 2026-03
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
Pfizer USD 207.62B 542M 2026-03
Prothena USD 349.89M 23.09M 2026-03
PTC Therapeutics USD 2.87B 29.66M 2026-03
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03